Cargando…
Overexpression of SMARCA2 or CAMK2D is associated with cisplatin resistance in human epithelial ovarian cancer
Ovarian cancer is one of the most lethal types of gynecological cancer. Drug resistance is a major underlying cause of treatment failure, which has lead to continued poor mortality and morbidity rates in patients. In the present study, highly sensitive transcriptome sequencing was performed to syste...
Autores principales: | Xu, Xiaoli, Zheng, Zhiguo, Jia, Lanlan, Suo, Shasha, Liu, Bowen, Shao, Tianning, Tu, Qinqing, Hua, Yuejin, Xu, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096159/ https://www.ncbi.nlm.nih.gov/pubmed/30127991 http://dx.doi.org/10.3892/ol.2018.9109 |
Ejemplares similares
-
De novo variants in CAMK2A and CAMK2B cause neurodevelopmental disorders
por: Akita, Tenpei, et al.
Publicado: (2018) -
Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
por: Urer, Halide Nur, et al.
Publicado: (2023) -
Adult Camk2a gene reinstatement restores the learning and plasticity deficits of Camk2a knockout mice
por: Rigter, Pomme M.F., et al.
Publicado: (2022) -
Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
por: Zhang, P, et al.
Publicado: (2014) -
Complex Alternative Splicing of the Smarca2 Gene Suggests the Importance of Smarca2-B Variants
por: Yang, Min, et al.
Publicado: (2011)